2:15 PM Delving into Clinical Trial Design for APOL1-Mediated Kidney Disease
Time: 2:15 pm
day: Conference Day 1
Details:
- Updates on the progression of the AZD2373 for the treatment of APOL1-Mediated kidney disease
- Delving into successful phase 2 study design in rare renal diseases
